BPI and cystic fibrosis: Anti-BPI antibodies in bacteremic patients (acute infections) were of low-avidity [84], compared to those in CF or bronchiectasis (chronic infections) patients [6,10], suggesting the breaking of tolerance to BPI arises through affinity maturation rather than cross-reactivity to P. aeruginosa [10] (Fig. 3B and C).